Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open-Label, Fixed Sequence, Phase 1 Study.
Journal: Clinical and translational science
Published: October 03, 2025
Pharmacokinetics and bioequivalence of a molnupiravir tablet formulation compared with the molnupiravir capsule formulation in healthy adult participants-a randomized, open-label, three-period, crossover study.
Journal: Antimicrobial agents and chemotherapy
Published: February 06, 2025
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.
Journal: Pulmonary therapy
Published: November 15, 2024
Assessment of pharmacokinetics and tolerability following single-dose administration of molnupiravir in participants with hepatic or renal impairment.
Journal: Clinical and translational science
Published: July 11, 2024
Molnupiravir: Mechanism of action, clinical, and translational science.
Journal: Clinical and translational science
Published: September 07, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Journal: Nature medicine
Published: March 18, 2023
Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
Journal: Diabetes
Published: January 03, 2022
Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.
Journal: The Journal of clinical investigation
Published: August 02, 2019
Thymic tolerance as a key brake on autoimmunity.
Journal: Nature immunology
Published: December 12, 2017
Last Updated: 09/26/2026